Curated News
By: NewsRamp Editorial Staff
July 30, 2025
Suboxone Tooth Decay Lawsuits Gain Momentum with New Evidence
TLDR
- Indivior faces increasing legal pressure as Suboxone lawsuits gain momentum, offering plaintiffs a stronger position for potential settlements or trial victories.
- The Suboxone MDL progresses with 100 cases in deeper discovery and four set for trial, amidst delays in pharmacy records and plaintiff pool adjustments.
- Suboxone lawsuits highlight the need for corporate accountability, aiming to improve patient safety and ensure justice for those suffering from preventable dental injuries.
- Emerging science links Suboxone to severe dental issues, reshaping legal strategies and offering new hope for affected individuals seeking compensation.
Impact - Why it Matters
This news is crucial for individuals who have suffered from Suboxone-related dental injuries, as it provides updates on the legal recourse available to them. The developments in the lawsuit could lead to significant compensation for victims and set a precedent for how pharmaceutical companies are held accountable for the side effects of their products. The ongoing litigation underscores the importance of transparency and accountability in the pharmaceutical industry, impacting not only current plaintiffs but also future cases involving drug-related injuries.
Summary
In a significant update from Lawsuit Legal News (LLN), the ongoing Suboxone tooth decay lawsuits against Indivior, the manufacturer of Suboxone, are gaining momentum due to strong scientific evidence linking the sublingual strips to severe dental issues. The federal multidistrict litigation (MDL) has seen key procedural milestones, including delays in accessing pharmacy records from Walgreens and adjustments to the plaintiff pool, with 48 individuals replaced in the early-stage discovery phase. Despite these developments, a settlement is not anticipated soon, with realistic projections pointing to late 2025 or early 2026 for meaningful discussions. LLN continues to be a pivotal resource for victims and their families, offering clear and timely updates on the litigation.
The July 2025 update highlights the challenges plaintiffs face, including record access delays and the refinement of the bellwether trial process. With 100 cases moving to deeper discovery and four advancing to trial, the legal battle against Indivior is shaping up to be a landmark case in pharmaceutical litigation. Victims of Suboxone-related dental injuries are encouraged to seek legal advice, with LLN providing a platform for the latest updates and connections to qualified attorneys.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Suboxone Tooth Decay Lawsuits Gain Momentum with New Evidence
